IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
| Revenue (Most Recent Fiscal Year) | $3.90B |
| Net Income (Most Recent Fiscal Year) | $887.87M |
| PE Ratio (Current Year Earnings Estimate) | 53.63 |
| PE Ratio (Trailing 12 Months) | 54.97 |
| PEG Ratio (Long Term Growth Estimate) | 4.14 |
| Price to Sales Ratio (Trailing 12 Months) | 13.28 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 35.46 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 55.77 |
| Pre-Tax Margin (Trailing 12 Months) | 30.56% |
| Net Margin (Trailing 12 Months) | 24.65% |
| Return on Equity (Trailing 12 Months) | 67.78% |
| Return on Assets (Trailing 12 Months) | 31.08% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.18 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.87 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.24 |
| Inventory Turnover (Trailing 12 Months) | 4.09 |
| Book Value per Share (Most Recent Fiscal Quarter) | $19.48 |
| Earnings per Share (Most Recent Fiscal Quarter) | $3.40 |
| Earnings per Share (Most Recent Fiscal Year) | $10.67 |
| Diluted Earnings per Share (Trailing 12 Months) | $12.61 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 79.85M |
| Free Float | 79.07M |
| Market Capitalization | $55.35B |
| Average Volume (Last 20 Days) | 0.59M |
| Beta (Past 60 Months) | 1.67 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.98% |
| Percentage Held By Institutions (Latest 13F Reports) | 87.84% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |